Avengebio

Developer of immunotherapies for the treatment of cancer

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 groups8 employees language avengebio.com

Registered entities

Investor mix

5 investors on record; lead investors include Xontogeny, CAM Capital.

Investor typeCountShare
Venture capital240%
Private equity120%
Accelerator & incubator120%
Other / undisclosed120%
Coming soon